Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SP100
|
ENSG00000067066.12 | SP100 nuclear antigen |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SP100 | hg19_v2_chr2_+_231280908_231280945 | 0.44 | 1.2e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_45909585 | 1.39 |
ENST00000593226.1
ENST00000418234.2 |
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like |
chr2_-_89399845 | 1.28 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
chr4_-_54518619 | 1.26 |
ENST00000507168.1
ENST00000510143.1 |
LNX1
|
ligand of numb-protein X 1, E3 ubiquitin protein ligase |
chr8_+_24241789 | 1.16 |
ENST00000256412.4
ENST00000538205.1 |
ADAMDEC1
|
ADAM-like, decysin 1 |
chr5_+_177540444 | 1.15 |
ENST00000274605.5
|
N4BP3
|
NEDD4 binding protein 3 |
chr2_+_90192768 | 1.11 |
ENST00000390275.2
|
IGKV1D-13
|
immunoglobulin kappa variable 1D-13 |
chr3_-_150996239 | 1.10 |
ENST00000309170.3
|
P2RY14
|
purinergic receptor P2Y, G-protein coupled, 14 |
chr8_+_24241969 | 1.10 |
ENST00000522298.1
|
ADAMDEC1
|
ADAM-like, decysin 1 |
chr10_-_4285835 | 1.05 |
ENST00000454470.1
|
LINC00702
|
long intergenic non-protein coding RNA 702 |
chr5_+_118604385 | 1.02 |
ENST00000274456.6
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
chr14_-_106586656 | 1.01 |
ENST00000390602.2
|
IGHV3-13
|
immunoglobulin heavy variable 3-13 |
chr13_-_97646604 | 0.90 |
ENST00000298440.1
ENST00000543457.1 ENST00000541038.1 |
OXGR1
|
oxoglutarate (alpha-ketoglutarate) receptor 1 |
chr16_+_85936295 | 0.90 |
ENST00000563180.1
ENST00000564617.1 ENST00000564803.1 |
IRF8
|
interferon regulatory factor 8 |
chr7_-_80551671 | 0.90 |
ENST00000419255.2
ENST00000544525.1 |
SEMA3C
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
chr10_-_4285923 | 0.90 |
ENST00000418372.1
ENST00000608792.1 |
LINC00702
|
long intergenic non-protein coding RNA 702 |
chr12_+_13044787 | 0.87 |
ENST00000534831.1
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A |
chr4_+_156588806 | 0.84 |
ENST00000513574.1
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr2_+_89975669 | 0.84 |
ENST00000474213.1
|
IGKV2D-30
|
immunoglobulin kappa variable 2D-30 |
chr5_-_43397184 | 0.83 |
ENST00000513525.1
|
CCL28
|
chemokine (C-C motif) ligand 28 |
chr5_+_40841276 | 0.80 |
ENST00000254691.5
|
CARD6
|
caspase recruitment domain family, member 6 |
chr11_+_35201826 | 0.80 |
ENST00000531873.1
|
CD44
|
CD44 molecule (Indian blood group) |
chr12_+_97306295 | 0.80 |
ENST00000457368.2
|
NEDD1
|
neural precursor cell expressed, developmentally down-regulated 1 |
chr2_+_220495800 | 0.79 |
ENST00000413743.1
|
SLC4A3
|
solute carrier family 4 (anion exchanger), member 3 |
chr19_-_44172396 | 0.77 |
ENST00000602141.1
ENST00000593939.1 ENST00000599546.1 |
PLAUR
|
plasminogen activator, urokinase receptor |
chr4_+_156588249 | 0.76 |
ENST00000393832.3
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr2_+_114163945 | 0.74 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
chr4_+_156588115 | 0.74 |
ENST00000455639.2
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr7_-_81635106 | 0.74 |
ENST00000443883.1
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
chr2_-_228582709 | 0.73 |
ENST00000541617.1
ENST00000409456.2 ENST00000409287.1 ENST00000258403.3 |
SLC19A3
|
solute carrier family 19 (thiamine transporter), member 3 |
chr6_+_31165901 | 0.73 |
ENST00000424675.1
|
HCG27
|
HLA complex group 27 (non-protein coding) |
chr17_+_45286706 | 0.72 |
ENST00000393450.1
ENST00000572303.1 |
MYL4
|
myosin, light chain 4, alkali; atrial, embryonic |
chr4_+_156588350 | 0.71 |
ENST00000296518.7
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr2_-_89292422 | 0.70 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chr6_+_116601265 | 0.70 |
ENST00000452085.3
|
DSE
|
dermatan sulfate epimerase |
chr4_+_15341442 | 0.70 |
ENST00000397700.2
ENST00000295297.4 |
C1QTNF7
|
C1q and tumor necrosis factor related protein 7 |
chr1_+_62439037 | 0.69 |
ENST00000545929.1
|
INADL
|
InaD-like (Drosophila) |
chr9_+_112887772 | 0.69 |
ENST00000259318.7
|
AKAP2
|
A kinase (PRKA) anchor protein 2 |
chr4_+_169418255 | 0.69 |
ENST00000505667.1
ENST00000511948.1 |
PALLD
|
palladin, cytoskeletal associated protein |
chr6_+_121756809 | 0.69 |
ENST00000282561.3
|
GJA1
|
gap junction protein, alpha 1, 43kDa |
chr16_-_69760409 | 0.68 |
ENST00000561500.1
ENST00000439109.2 ENST00000564043.1 ENST00000379046.2 ENST00000379047.3 |
NQO1
|
NAD(P)H dehydrogenase, quinone 1 |
chr4_-_90757364 | 0.67 |
ENST00000508895.1
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr5_+_140514782 | 0.67 |
ENST00000231134.5
|
PCDHB5
|
protocadherin beta 5 |
chr19_+_12175596 | 0.67 |
ENST00000441304.2
|
ZNF844
|
zinc finger protein 844 |
chr14_-_106478603 | 0.67 |
ENST00000390596.2
|
IGHV4-4
|
immunoglobulin heavy variable 4-4 |
chr5_+_118604439 | 0.66 |
ENST00000388882.5
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
chr19_+_44331444 | 0.65 |
ENST00000324461.7
|
ZNF283
|
zinc finger protein 283 |
chr5_+_148651469 | 0.64 |
ENST00000515000.1
|
AFAP1L1
|
actin filament associated protein 1-like 1 |
chr8_+_104310661 | 0.64 |
ENST00000522566.1
|
FZD6
|
frizzled family receptor 6 |
chr1_-_108735440 | 0.63 |
ENST00000370041.4
|
SLC25A24
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24 |
chr19_+_44331493 | 0.62 |
ENST00000588797.1
|
ZNF283
|
zinc finger protein 283 |
chr6_+_135502408 | 0.62 |
ENST00000341911.5
ENST00000442647.2 ENST00000316528.8 |
MYB
|
v-myb avian myeloblastosis viral oncogene homolog |
chr5_+_148651409 | 0.61 |
ENST00000296721.4
|
AFAP1L1
|
actin filament associated protein 1-like 1 |
chr5_+_54455946 | 0.61 |
ENST00000503787.1
ENST00000296734.6 ENST00000515370.1 |
GPX8
|
glutathione peroxidase 8 (putative) |
chr1_+_24829384 | 0.60 |
ENST00000374395.4
ENST00000436717.2 |
RCAN3
|
RCAN family member 3 |
chr8_-_19459993 | 0.60 |
ENST00000454498.2
ENST00000520003.1 |
CSGALNACT1
|
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
chr16_+_55512742 | 0.59 |
ENST00000568715.1
ENST00000219070.4 |
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
chr5_+_40841410 | 0.59 |
ENST00000381677.3
|
CARD6
|
caspase recruitment domain family, member 6 |
chr19_+_44331555 | 0.58 |
ENST00000590950.1
|
ZNF283
|
zinc finger protein 283 |
chr1_+_90098606 | 0.58 |
ENST00000370454.4
|
LRRC8C
|
leucine rich repeat containing 8 family, member C |
chr8_+_94767072 | 0.58 |
ENST00000452276.1
ENST00000453321.3 ENST00000498673.1 ENST00000518319.1 |
TMEM67
|
transmembrane protein 67 |
chr1_-_117210290 | 0.57 |
ENST00000369483.1
ENST00000369486.3 |
IGSF3
|
immunoglobulin superfamily, member 3 |
chrX_+_70586140 | 0.57 |
ENST00000276072.3
|
TAF1
|
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa |
chr19_+_56989609 | 0.57 |
ENST00000601875.1
|
ZNF667-AS1
|
ZNF667 antisense RNA 1 (head to head) |
chr19_+_58095501 | 0.56 |
ENST00000536878.2
ENST00000597850.1 ENST00000597219.1 ENST00000598689.1 ENST00000599456.1 ENST00000307468.4 |
ZIK1
|
zinc finger protein interacting with K protein 1 |
chr4_-_5710257 | 0.55 |
ENST00000344938.1
ENST00000344408.5 |
EVC2
|
Ellis van Creveld syndrome 2 |
chr11_-_76381781 | 0.55 |
ENST00000260061.5
ENST00000404995.1 |
LRRC32
|
leucine rich repeat containing 32 |
chr2_+_85132749 | 0.55 |
ENST00000233143.4
|
TMSB10
|
thymosin beta 10 |
chr6_-_27806117 | 0.54 |
ENST00000330180.2
|
HIST1H2AK
|
histone cluster 1, H2ak |
chr22_+_32455111 | 0.54 |
ENST00000543737.1
|
SLC5A1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1 |
chr8_+_69242957 | 0.53 |
ENST00000518698.1
ENST00000539993.1 |
C8orf34
|
chromosome 8 open reading frame 34 |
chr11_+_62037622 | 0.53 |
ENST00000227918.2
ENST00000525380.1 |
SCGB2A2
|
secretoglobin, family 2A, member 2 |
chrX_-_50386648 | 0.53 |
ENST00000460112.3
|
SHROOM4
|
shroom family member 4 |
chr16_+_71392616 | 0.53 |
ENST00000349553.5
ENST00000302628.4 ENST00000562305.1 |
CALB2
|
calbindin 2 |
chr6_+_135502501 | 0.52 |
ENST00000527615.1
ENST00000420123.2 ENST00000525369.1 ENST00000528774.1 ENST00000534121.1 ENST00000534044.1 ENST00000533624.1 |
MYB
|
v-myb avian myeloblastosis viral oncogene homolog |
chr10_-_28623368 | 0.52 |
ENST00000441595.2
|
MPP7
|
membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) |
chr2_+_241544834 | 0.52 |
ENST00000319838.5
ENST00000403859.1 ENST00000438013.2 |
GPR35
|
G protein-coupled receptor 35 |
chr6_+_29691056 | 0.51 |
ENST00000414333.1
ENST00000334668.4 ENST00000259951.7 |
HLA-F
|
major histocompatibility complex, class I, F |
chr19_+_12203069 | 0.51 |
ENST00000430298.2
ENST00000339302.4 |
ZNF788
ZNF788
|
zinc finger family member 788 Zinc finger protein 788 |
chr3_+_62304648 | 0.51 |
ENST00000462069.1
ENST00000232519.5 ENST00000465142.1 |
C3orf14
|
chromosome 3 open reading frame 14 |
chr11_+_60145948 | 0.51 |
ENST00000300184.3
ENST00000358246.1 |
MS4A7
|
membrane-spanning 4-domains, subfamily A, member 7 |
chr8_+_104383728 | 0.50 |
ENST00000330295.5
|
CTHRC1
|
collagen triple helix repeat containing 1 |
chr11_+_102980126 | 0.50 |
ENST00000375735.2
|
DYNC2H1
|
dynein, cytoplasmic 2, heavy chain 1 |
chr18_-_46475696 | 0.50 |
ENST00000591805.1
|
SMAD7
|
SMAD family member 7 |
chr3_+_62304712 | 0.49 |
ENST00000494481.1
|
C3orf14
|
chromosome 3 open reading frame 14 |
chr4_+_41540160 | 0.49 |
ENST00000503057.1
ENST00000511496.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr2_+_201994569 | 0.49 |
ENST00000457277.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr6_+_26204825 | 0.49 |
ENST00000360441.4
|
HIST1H4E
|
histone cluster 1, H4e |
chr13_+_114462193 | 0.49 |
ENST00000375353.3
|
TMEM255B
|
transmembrane protein 255B |
chr10_-_69425399 | 0.48 |
ENST00000330298.6
|
CTNNA3
|
catenin (cadherin-associated protein), alpha 3 |
chr11_-_5248294 | 0.48 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
chr19_-_44172467 | 0.48 |
ENST00000599892.1
|
PLAUR
|
plasminogen activator, urokinase receptor |
chr6_+_150285135 | 0.48 |
ENST00000229708.3
|
ULBP1
|
UL16 binding protein 1 |
chr5_-_157161727 | 0.48 |
ENST00000599823.1
|
AC026407.1
|
Uncharacterized protein |
chr11_-_118550375 | 0.48 |
ENST00000525958.1
ENST00000264029.4 ENST00000397925.1 ENST00000529101.1 |
TREH
|
trehalase (brush-border membrane glycoprotein) |
chr7_-_120498357 | 0.47 |
ENST00000415871.1
ENST00000222747.3 ENST00000430985.1 |
TSPAN12
|
tetraspanin 12 |
chr9_-_137809718 | 0.47 |
ENST00000371806.3
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1 |
chr2_+_183943464 | 0.47 |
ENST00000354221.4
|
DUSP19
|
dual specificity phosphatase 19 |
chr12_+_56435637 | 0.47 |
ENST00000356464.5
ENST00000552361.1 |
RPS26
|
ribosomal protein S26 |
chr6_+_32709119 | 0.46 |
ENST00000374940.3
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2 |
chr4_+_89299994 | 0.46 |
ENST00000264346.7
|
HERC6
|
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
chr12_+_12938541 | 0.46 |
ENST00000356591.4
|
APOLD1
|
apolipoprotein L domain containing 1 |
chr13_-_30169807 | 0.46 |
ENST00000380752.5
|
SLC7A1
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
chr14_-_106471723 | 0.46 |
ENST00000390595.2
|
IGHV1-3
|
immunoglobulin heavy variable 1-3 |
chr7_-_151330218 | 0.46 |
ENST00000476632.1
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
chr3_+_8543561 | 0.45 |
ENST00000397386.3
|
LMCD1
|
LIM and cysteine-rich domains 1 |
chr19_-_52391220 | 0.45 |
ENST00000419138.1
|
ZNF577
|
zinc finger protein 577 |
chr6_+_29691198 | 0.45 |
ENST00000440587.2
ENST00000434407.2 |
HLA-F
|
major histocompatibility complex, class I, F |
chr6_-_18249971 | 0.44 |
ENST00000507591.1
|
DEK
|
DEK oncogene |
chr7_+_98971863 | 0.44 |
ENST00000443222.1
ENST00000414376.1 |
ARPC1B
|
actin related protein 2/3 complex, subunit 1B, 41kDa |
chr3_+_155838337 | 0.43 |
ENST00000490337.1
ENST00000389636.5 |
KCNAB1
|
potassium voltage-gated channel, shaker-related subfamily, beta member 1 |
chr14_-_24898731 | 0.43 |
ENST00000267406.6
|
CBLN3
|
cerebellin 3 precursor |
chr1_-_158656488 | 0.43 |
ENST00000368147.4
|
SPTA1
|
spectrin, alpha, erythrocytic 1 (elliptocytosis 2) |
chr4_-_57522673 | 0.43 |
ENST00000381255.3
ENST00000317745.7 ENST00000555760.2 ENST00000556614.2 |
HOPX
|
HOP homeobox |
chr6_-_41888843 | 0.43 |
ENST00000434077.1
ENST00000409312.1 |
MED20
|
mediator complex subunit 20 |
chr3_-_16524357 | 0.43 |
ENST00000432519.1
|
RFTN1
|
raftlin, lipid raft linker 1 |
chr4_+_37245799 | 0.42 |
ENST00000309447.5
|
KIAA1239
|
KIAA1239 |
chr2_+_168043793 | 0.42 |
ENST00000409273.1
ENST00000409605.1 |
XIRP2
|
xin actin-binding repeat containing 2 |
chr21_-_43346790 | 0.42 |
ENST00000329623.7
|
C2CD2
|
C2 calcium-dependent domain containing 2 |
chr11_+_60145967 | 0.41 |
ENST00000534016.1
|
MS4A7
|
membrane-spanning 4-domains, subfamily A, member 7 |
chr15_+_42066888 | 0.41 |
ENST00000510535.1
|
MAPKBP1
|
mitogen-activated protein kinase binding protein 1 |
chr5_+_140593509 | 0.41 |
ENST00000341948.4
|
PCDHB13
|
protocadherin beta 13 |
chr2_-_37068530 | 0.41 |
ENST00000593798.1
|
AC007382.1
|
Uncharacterized protein |
chr19_+_41103063 | 0.41 |
ENST00000308370.7
|
LTBP4
|
latent transforming growth factor beta binding protein 4 |
chr3_+_153202284 | 0.41 |
ENST00000446603.2
|
C3orf79
|
chromosome 3 open reading frame 79 |
chr4_+_86396321 | 0.40 |
ENST00000503995.1
|
ARHGAP24
|
Rho GTPase activating protein 24 |
chr11_+_6947720 | 0.40 |
ENST00000414517.2
|
ZNF215
|
zinc finger protein 215 |
chr20_+_30309001 | 0.39 |
ENST00000597287.1
|
AL160175.1
|
AL160175.1 |
chr1_-_79472365 | 0.39 |
ENST00000370742.3
|
ELTD1
|
EGF, latrophilin and seven transmembrane domain containing 1 |
chr17_-_3571934 | 0.39 |
ENST00000225525.3
|
TAX1BP3
|
Tax1 (human T-cell leukemia virus type I) binding protein 3 |
chr19_+_52901094 | 0.39 |
ENST00000391788.2
ENST00000436397.1 ENST00000391787.2 ENST00000360465.3 ENST00000494167.2 ENST00000493272.1 |
ZNF528
|
zinc finger protein 528 |
chr18_+_3247779 | 0.38 |
ENST00000578611.1
ENST00000583449.1 |
MYL12A
|
myosin, light chain 12A, regulatory, non-sarcomeric |
chr19_-_7812446 | 0.38 |
ENST00000394173.4
ENST00000301357.8 |
CD209
|
CD209 molecule |
chr8_+_59465728 | 0.38 |
ENST00000260130.4
ENST00000422546.2 ENST00000447182.2 ENST00000413219.2 ENST00000424270.2 ENST00000523483.1 ENST00000520168.1 |
SDCBP
|
syndecan binding protein (syntenin) |
chr15_+_45021183 | 0.37 |
ENST00000559390.1
|
TRIM69
|
tripartite motif containing 69 |
chr3_-_11685345 | 0.37 |
ENST00000430365.2
|
VGLL4
|
vestigial like 4 (Drosophila) |
chr13_-_36944307 | 0.37 |
ENST00000355182.4
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome) |
chr19_+_48281928 | 0.37 |
ENST00000593892.1
|
SEPW1
|
selenoprotein W, 1 |
chr2_+_201994042 | 0.37 |
ENST00000417748.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr10_+_60272814 | 0.37 |
ENST00000373886.3
|
BICC1
|
bicaudal C homolog 1 (Drosophila) |
chr16_-_57831914 | 0.37 |
ENST00000421376.2
|
KIFC3
|
kinesin family member C3 |
chr7_-_7782204 | 0.37 |
ENST00000418534.2
|
AC007161.5
|
AC007161.5 |
chr7_+_97361218 | 0.37 |
ENST00000319273.5
|
TAC1
|
tachykinin, precursor 1 |
chr1_+_2487800 | 0.37 |
ENST00000355716.4
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14 |
chr1_+_104068312 | 0.37 |
ENST00000524631.1
ENST00000531883.1 ENST00000533099.1 ENST00000527062.1 |
RNPC3
|
RNA-binding region (RNP1, RRM) containing 3 |
chr22_-_37976082 | 0.36 |
ENST00000215886.4
|
LGALS2
|
lectin, galactoside-binding, soluble, 2 |
chr11_-_76381029 | 0.36 |
ENST00000407242.2
ENST00000421973.1 |
LRRC32
|
leucine rich repeat containing 32 |
chr6_+_26199737 | 0.36 |
ENST00000359985.1
|
HIST1H2BF
|
histone cluster 1, H2bf |
chr15_-_72410350 | 0.36 |
ENST00000356056.5
ENST00000424560.1 ENST00000444904.1 |
MYO9A
|
myosin IXA |
chr7_+_30589829 | 0.36 |
ENST00000579437.1
|
RP4-777O23.1
|
RP4-777O23.1 |
chr2_-_183106641 | 0.36 |
ENST00000346717.4
|
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
chr9_+_5890802 | 0.36 |
ENST00000381477.3
ENST00000381476.1 ENST00000381471.1 |
MLANA
|
melan-A |
chrX_+_100353153 | 0.36 |
ENST00000423383.1
ENST00000218507.5 ENST00000403304.2 ENST00000435570.1 |
CENPI
|
centromere protein I |
chr17_-_8079648 | 0.35 |
ENST00000449985.2
ENST00000532998.1 ENST00000437139.2 ENST00000533070.1 ENST00000316425.5 |
TMEM107
|
transmembrane protein 107 |
chr19_-_36822595 | 0.35 |
ENST00000585356.1
ENST00000438368.2 ENST00000590622.1 |
LINC00665
|
long intergenic non-protein coding RNA 665 |
chr19_+_38085731 | 0.35 |
ENST00000589117.1
|
ZNF540
|
zinc finger protein 540 |
chr19_+_7580103 | 0.35 |
ENST00000596712.1
|
ZNF358
|
zinc finger protein 358 |
chr17_-_15587602 | 0.35 |
ENST00000416464.2
ENST00000578237.1 ENST00000581200.1 |
TRIM16
|
tripartite motif containing 16 |
chr1_+_2487402 | 0.35 |
ENST00000451778.1
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14 |
chr22_+_27068704 | 0.35 |
ENST00000444388.1
ENST00000450963.1 ENST00000449017.1 |
CTA-211A9.5
|
CTA-211A9.5 |
chr15_-_72410306 | 0.35 |
ENST00000566885.1
|
MYO9A
|
myosin IXA |
chrX_+_15767971 | 0.34 |
ENST00000479740.1
ENST00000454127.2 |
CA5B
|
carbonic anhydrase VB, mitochondrial |
chr17_-_8079632 | 0.34 |
ENST00000431792.2
|
TMEM107
|
transmembrane protein 107 |
chr4_-_57522598 | 0.34 |
ENST00000553379.2
|
HOPX
|
HOP homeobox |
chr12_+_2079939 | 0.34 |
ENST00000543114.1
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
chr6_-_41888814 | 0.34 |
ENST00000409060.1
ENST00000265350.4 |
MED20
|
mediator complex subunit 20 |
chr1_+_2487631 | 0.34 |
ENST00000409119.1
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14 |
chr10_-_103815874 | 0.34 |
ENST00000370033.4
ENST00000311122.5 |
C10orf76
|
chromosome 10 open reading frame 76 |
chr4_+_169418195 | 0.34 |
ENST00000261509.6
ENST00000335742.7 |
PALLD
|
palladin, cytoskeletal associated protein |
chr16_+_22518495 | 0.33 |
ENST00000541154.1
|
NPIPB5
|
nuclear pore complex interacting protein family, member B5 |
chr12_-_110318130 | 0.33 |
ENST00000540772.1
|
GLTP
|
glycolipid transfer protein |
chr3_+_40498783 | 0.33 |
ENST00000338970.6
ENST00000396203.2 ENST00000416518.1 |
RPL14
|
ribosomal protein L14 |
chr13_+_43597269 | 0.33 |
ENST00000379221.2
|
DNAJC15
|
DnaJ (Hsp40) homolog, subfamily C, member 15 |
chr17_+_39969183 | 0.33 |
ENST00000321562.4
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
chr19_+_38085768 | 0.32 |
ENST00000316433.4
ENST00000590588.1 ENST00000586134.1 ENST00000586792.1 |
ZNF540
|
zinc finger protein 540 |
chr6_-_46424599 | 0.32 |
ENST00000405162.1
|
RCAN2
|
regulator of calcineurin 2 |
chr2_+_29353520 | 0.32 |
ENST00000438819.1
|
CLIP4
|
CAP-GLY domain containing linker protein family, member 4 |
chr13_+_114567131 | 0.32 |
ENST00000608651.1
|
GAS6-AS2
|
GAS6 antisense RNA 2 (head to head) |
chrX_-_10588595 | 0.31 |
ENST00000423614.1
ENST00000317552.4 |
MID1
|
midline 1 (Opitz/BBB syndrome) |
chr19_+_53836985 | 0.31 |
ENST00000601857.1
ENST00000595091.1 ENST00000458035.1 |
ZNF845
|
zinc finger protein 845 |
chr1_+_44115814 | 0.31 |
ENST00000372396.3
|
KDM4A
|
lysine (K)-specific demethylase 4A |
chr2_-_70475730 | 0.31 |
ENST00000445587.1
ENST00000433529.2 ENST00000415783.2 |
TIA1
|
TIA1 cytotoxic granule-associated RNA binding protein |
chr6_-_33048483 | 0.31 |
ENST00000419277.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
chr15_-_72410455 | 0.31 |
ENST00000569314.1
|
MYO9A
|
myosin IXA |
chr7_+_117824086 | 0.31 |
ENST00000249299.2
ENST00000424702.1 |
NAA38
|
N(alpha)-acetyltransferase 38, NatC auxiliary subunit |
chr9_-_99775862 | 0.31 |
ENST00000602917.1
ENST00000375223.4 |
HIATL2
|
hippocampus abundant transcript-like 2 |
chr21_-_48024986 | 0.30 |
ENST00000291700.4
ENST00000367071.4 |
S100B
|
S100 calcium binding protein B |
chr6_+_32407619 | 0.30 |
ENST00000395388.2
ENST00000374982.5 |
HLA-DRA
|
major histocompatibility complex, class II, DR alpha |
chr19_-_52391142 | 0.30 |
ENST00000446514.1
ENST00000458390.1 ENST00000420592.1 ENST00000451628.2 ENST00000592321.1 ENST00000591320.1 ENST00000412216.1 ENST00000301399.5 |
ZNF577
|
zinc finger protein 577 |
chr14_+_75745477 | 0.30 |
ENST00000303562.4
ENST00000554617.1 ENST00000554212.1 ENST00000535987.1 ENST00000555242.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr7_+_117824210 | 0.30 |
ENST00000422760.1
ENST00000411938.1 |
NAA38
|
N(alpha)-acetyltransferase 38, NatC auxiliary subunit |
chr19_-_53400813 | 0.30 |
ENST00000595635.1
ENST00000594741.1 ENST00000597111.1 ENST00000593618.1 ENST00000597909.1 |
ZNF320
|
zinc finger protein 320 |
chr21_-_27462351 | 0.30 |
ENST00000448850.1
|
APP
|
amyloid beta (A4) precursor protein |
chr2_-_47403642 | 0.30 |
ENST00000456319.1
ENST00000409563.1 ENST00000272298.7 |
CALM2
|
calmodulin 2 (phosphorylase kinase, delta) |
chr2_+_201987200 | 0.30 |
ENST00000425030.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr18_-_52989217 | 0.29 |
ENST00000570287.2
|
TCF4
|
transcription factor 4 |
chr7_+_128095900 | 0.29 |
ENST00000435296.2
|
HILPDA
|
hypoxia inducible lipid droplet-associated |
chr19_-_54876414 | 0.29 |
ENST00000474878.1
ENST00000348231.4 |
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1 |
chr7_+_870547 | 0.29 |
ENST00000457598.1
|
SUN1
|
Sad1 and UNC84 domain containing 1 |
chr3_-_138553779 | 0.29 |
ENST00000461451.1
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
chr12_-_10978957 | 0.29 |
ENST00000240619.2
|
TAS2R10
|
taste receptor, type 2, member 10 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 3.1 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.5 | 1.4 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.2 | 0.7 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.2 | 1.0 | GO:1902957 | negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
0.2 | 0.6 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.2 | 0.5 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.2 | 1.3 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.1 | 0.7 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.1 | 0.8 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.5 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.1 | 0.5 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.4 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
0.1 | 0.5 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.1 | 1.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 1.4 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 0.6 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
0.1 | 1.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.3 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.1 | 1.0 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.1 | 0.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.4 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.1 | 0.7 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.1 | 0.7 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.1 | 0.8 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.4 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) calcium ion regulated lysosome exocytosis(GO:1990927) |
0.1 | 0.5 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.5 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.9 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.1 | 0.3 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.1 | 0.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.4 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.1 | 0.3 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.1 | 0.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.6 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.1 | 0.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.2 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.1 | 0.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.5 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 0.2 | GO:0061567 | dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
0.1 | 0.3 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.1 | 0.5 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.2 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.1 | 1.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.2 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.1 | 0.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 0.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.2 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.1 | 0.3 | GO:2000691 | regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.1 | 0.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 0.5 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.5 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.1 | 0.2 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.1 | 0.7 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.0 | 0.3 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 1.4 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.1 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.0 | 0.5 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 0.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.1 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.0 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.3 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.0 | 0.3 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.0 | 0.1 | GO:0034059 | response to anoxia(GO:0034059) |
0.0 | 0.6 | GO:0015866 | ADP transport(GO:0015866) |
0.0 | 0.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.0 | 1.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.9 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 1.8 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.5 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 1.1 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.0 | 0.2 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.0 | 0.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.1 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.0 | 0.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.0 | 0.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.2 | GO:0051414 | response to cortisol(GO:0051414) |
0.0 | 0.7 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 0.2 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.0 | 0.2 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.0 | 1.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.4 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.0 | 0.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.6 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
0.0 | 0.5 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.0 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.2 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.0 | 0.8 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.1 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.0 | 0.3 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.0 | 0.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.2 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.0 | 0.1 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.0 | 0.3 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.2 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.0 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.1 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.0 | 0.4 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.2 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.0 | 0.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.5 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.5 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.3 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.1 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.0 | 1.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.1 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.0 | 0.0 | GO:1903464 | negative regulation of mitotic cell cycle DNA replication(GO:1903464) |
0.0 | 0.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.1 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
0.0 | 0.4 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) mRNA methylation(GO:0080009) |
0.0 | 0.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.0 | 0.5 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.0 | 0.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.8 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 1.3 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:0042325 | regulation of phosphorylation(GO:0042325) |
0.0 | 0.1 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
0.0 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:1904925 | negative regulation of mitochondrial fusion(GO:0010637) regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.0 | 0.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.2 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.0 | 0.4 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.7 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.7 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 3.6 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.0 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.4 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.1 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.0 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.1 | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.0 | 0.1 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.0 | 0.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.0 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.0 | 0.7 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.1 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.0 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.0 | 0.0 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.0 | 0.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.6 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 1.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.1 | GO:0050911 | detection of stimulus involved in sensory perception(GO:0050906) detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.3 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.0 | 0.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.0 | 0.5 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.0 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
0.0 | 0.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0001701 | in utero embryonic development(GO:0001701) |
0.0 | 0.2 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 1.7 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.1 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.6 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.5 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.4 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.1 | 0.4 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.1 | 0.8 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 1.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 3.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 1.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 1.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 0.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.1 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 1.3 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 1.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 1.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 1.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
0.0 | 0.2 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 0.5 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 1.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.2 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
0.0 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.3 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.3 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.3 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.0 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.2 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.0 | 0.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 0.2 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 0.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.0 | 0.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.8 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 1.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 1.7 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.0 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 1.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.0 | 0.3 | GO:0070187 | telosome(GO:0070187) |
0.0 | 1.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.0 | 0.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 0.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.9 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.1 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.7 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.2 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.0 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.0 | 0.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.7 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
0.2 | 0.7 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) |
0.2 | 0.7 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.2 | 1.3 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.2 | 0.5 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.1 | 0.7 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.1 | 0.6 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 0.7 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 1.0 | GO:0046979 | TAP2 binding(GO:0046979) |
0.1 | 0.7 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.1 | 0.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.5 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 0.4 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.1 | 0.5 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.4 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.1 | 0.3 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.1 | 1.1 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.1 | 1.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.3 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.1 | 3.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.6 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.1 | 0.4 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
0.1 | 0.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.2 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
0.1 | 0.4 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
0.1 | 0.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.5 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 1.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 0.6 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.1 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.4 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.1 | 0.2 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 0.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.1 | 0.3 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.6 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 2.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.3 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 1.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.5 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.0 | 0.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.0 | 0.1 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.0 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.5 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.0 | 0.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.6 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.2 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
0.0 | 0.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.1 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
0.0 | 0.5 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.0 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.2 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.0 | 1.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.1 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.0 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.1 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.0 | 0.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.2 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
0.0 | 1.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.3 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.0 | 0.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.0 | 0.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 1.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.1 | GO:0072545 | tyrosine binding(GO:0072545) |
0.0 | 0.1 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.0 | 0.8 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.5 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 6.4 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 1.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 0.6 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.4 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.0 | 0.2 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.4 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.4 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.1 | GO:0043532 | angiostatin binding(GO:0043532) |
0.0 | 0.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.1 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.0 | 0.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.0 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.0 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 2.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.1 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.0 | 0.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.0 | GO:0016768 | spermine synthase activity(GO:0016768) |
0.0 | 0.0 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
0.0 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 1.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 1.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 1.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 3.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 1.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 1.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 1.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 1.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.2 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 0.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |